(RTTNews) - Novocure (NVCR) announced the FDA approved new Head Flexible Electrode transducer arrays for use with Optune Gio for the treatment of adult patients with glioblastoma multiforme. Novocure ...
Adjuvant therapy with gemcitabine and stereotactic body radiation therapy versus gemcitabine alone for resected stage II pancreatic cancer: A prospective, randomized, open label, single-center trial.
Ultrasonic transducers are incredible, with them you can detect distances, as well as levitate and peer through objects. They can emit and receive ultrasonic soundwaves (typically above 18khz) and ...
In a recently published study in the journal EPSL neuroelectronics, researchers from The Pennsylvania State University and Washington University in St. Louis have introduced a modular 16-channel ...
EF-33 will test the potential incremental survival benefit of Tumor Treating Fields delivered using high-intensity arrays in patients with recurrent glioblastoma ST. HELIER, Jersey--(BUSINESS WIRE)-- ...
July 6 (UPI) --Northrop Grumman reports it has received a contract from the U.S. Navy to produce Transducer Array/Nose Shell Assemblies for MK 48 heavyweight torpedoes, the company announced on ...
ROOT, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) approved its new Head Flexible Electrode (HFE) transducer arrays for use ...
New flexible arrays are lighter, thinner and designed to improve comfort for Optune Gio users ROOT, Switzerland--(BUSINESS WIRE)-- Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results